Share on LinkedInShare on LinkedIn

ARTICLE · 26 JULY 2022

Psychedelics And VR: Exploring New Horizons In Therapeutics And IP

Fox Rothschild LLP
Fox Rothschild LLP
Contributor
Explore more from Fox Rothschild LLP

Scientists have argued for a while that psychedelic experiences and virtual reality share the common ability to alter perception and visual processing. EEG recordings suggest that both...

United StatesIntellectual Property

Scientists have argued for a while that psychedelic experiences and virtual reality share the common ability to alter perception and visual processing. EEG recordings suggest that both may induce comparable cortical activity and elicit similar neurological responses. Now, a new generation of researchers are combining virtual reality and psychedelics to create new therapeutic paradigms that improve patient care, also creating opportunities to file patents that capture the evolving innovation.

Several companies have publicized patent filings describing a combination of virtual reality and psychedelics. For example, in June 2021, Goodness Growth Holdings, Inc., announced that its subsidiary, Resurgent Biosciences (Resurgent), had filed for a US patent to create an expansive suite of virtual reality (VR) applications that could be used during psychedelic-based therapies to enhance and guide patients through the experience and potentially create optimized, longer-lasting

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from